FY25 decipher testing for mamc
Ended Awarded Last action
- Contract number
- W81K0224F0148
- Awardee
-
Veracyte Labs SD Corporation UEI DKKCNLTYT2A1 Part of Veracyte, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $48,609
Award facts
- Opportunity
-
- Decipher Prostate Genomic Classifer Testing Services Solicitation · W81K0224Q0118 · Posted Sep 4, 2024
- Contract value 100% obligated
- $48,608.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$48,609 | |
| Funding Only Action | $97,218 | |
| Original award | $0 |
About this award
Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a delivery order valued at $48,608.85 by the Defense Health Agency for FY25 Decipher Prostate Testing services. The contract, which is firm fixed price with no set-aside designation, is scheduled for completion by September 30, 2025, and will be performed in San Diego, California. This delivery order represents task order activity under an existing Indefinite Delivery Vehicle with the Defense Health Agency valued at $194,435.40 for Decipher Prostate Genomic Classifier testing, established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II).
The Decipher Prostate Cancer Test is a proprietary genomic diagnostic service that analyzes tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential, enabling clinicians to make more informed treatment decisions for service members. Veracyte Labs SD Corporation has established itself as a key provider of specialized molecular diagnostic services across federal healthcare agencies, with a demonstrated track record of serving the Department of Veterans Affairs and the Defense Health Agency through multiple contract vehicles nationwide. The non-competitive nature of this award reflects the specialized and proprietary nature of Veracyte's genomic testing capabilities within the precision medicine landscape.
Quick answers
Who was awarded contract W81K0224F0148?
W81K0224F0148 was awarded to Veracyte Labs SD Corporation by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0224F0148 worth?
The government has obligated $48,609 on W81K0224F0148.
Which agency awarded contract W81K0224F0148?
Medical Command (Department of the Army) awarded W81K0224F0148, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0148 an order under another contract?
Yes. W81K0224F0148 is a delivery order under W81K0224D0013, an indefinite delivery contract.
Was contract W81K0224F0148 competed?
The extent of competition for W81K0224F0148 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award